KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The list includes pneumonia, tuberculosis, gonorrhea, blood poisoning, and food-borne diseases. Resistance to drugs used to treat infections ... as well as other groups of antibiotics known as the ...

Of all the cephalosporins, only first-generation drugs should be considered for the treatment of GAS pharyngitis. The clearest advantage of cephalosporins is for patients in whom eradication of ...

Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

Cephalosporin Drugs Market Snapshot 2024-2032: The <a href=https://www.reportsinsights.com/sample/48690#utm_source=LKD&utm_id=LKD>Cephalosporin Drugs Market 2024 ...

A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...

Cephalosporin Drugs Market Snapshot 2025-2032: The Cephalosporin Drugs Market 2025 report offers an in-depth exploration of market dynamics, leveraging comprehensive secondary research to provide ...

Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...